Religare Enterprises Ltd
Religare Enterprise Ltd, incorporated in 1984, is a diversified financial services company with presence all over India, operating through its subsidiaries. The Co. provides loans to SMEs, Affordable Housing Finance, Health Insurance and Retail Broking. REL’s subsidiaries service over 11 lakh clients from over 1,275 locations having presence in more than 400 cities.[1][2]
- Market Cap ₹ 7,148 Cr.
- Current Price ₹ 217
- High / Low ₹ 281 / 159
- Stock P/E
- Book Value ₹ 65.4
- Dividend Yield 0.00 %
- ROCE 0.08 %
- ROE -0.48 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 3.31 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -11.4% over past five years.
- Company has a low return on equity of 0.50% over last 3 years.
- Working capital days have increased from -903 days to 285 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57 | 122 | 190 | 114 | 497 | 35 | 57 | 33 | 21 | 114 | 28 | 31 | 15 | |
| 228 | 128 | 92 | 11 | 8 | 30 | 346 | 136 | 194 | 49 | 52 | 53 | 61 | |
| Operating Profit | -172 | -7 | 98 | 103 | 490 | 5 | -290 | -102 | -174 | 64 | -25 | -22 | -46 |
| OPM % | -303% | -5% | 52% | 91% | 98% | 13% | -508% | -307% | -845% | 57% | -88% | -71% | -316% |
| -635 | -711 | 6 | 0 | -279 | -7 | 15 | 2 | -130 | 5 | 2 | 27 | 34 | |
| Interest | 6 | 35 | 223 | 194 | 110 | 156 | 57 | 45 | 6 | 4 | 2 | 12 | 24 |
| Depreciation | 4 | 3 | 3 | 3 | 2 | 0 | 2 | 1 | 1 | 1 | 2 | 3 | 5 |
| Profit before tax | -817 | -755 | -122 | -93 | 99 | -158 | -333 | -146 | -310 | 64 | -27 | -10 | -42 |
| Tax % | 0% | -1% | -6% | -11% | 16% | -1% | 2% | -0% | -0% | 1% | 3% | 0% | |
| -816 | -761 | -130 | -104 | 84 | -159 | -326 | -146 | -310 | 64 | -26 | -10 | -35 | |
| EPS in Rs | -54.67 | -50.93 | -8.66 | -5.80 | 4.70 | -8.93 | -18.28 | -6.73 | -12.02 | 2.47 | -0.82 | -0.32 | -1.08 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | -11% |
| 3 Years: | 15% |
| TTM: | -38% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 24% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 49% |
| 3 Years: | 34% |
| 1 Year: | 35% |
| Return on Equity | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -3% |
| 3 Years: | 1% |
| Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 149 | 149 | 150 | 178 | 178 | 178 | 178 | 217 | 258 | 259 | 319 | 324 | 328 |
| Reserves | 2,768 | 2,004 | 1,880 | 2,253 | 2,337 | 1,679 | 1,330 | 1,347 | 1,252 | 1,320 | 1,819 | 1,818 | 1,827 |
| Preference Capital | 56 | 56 | 56 | 25 | 25 | 26 | -0 | 75 | 78 | 82 | 84 | 84 | |
| 5 | 1,251 | 1,751 | 725 | 819 | 1,275 | 548 | 306 | 255 | 257 | 9 | 135 | 141 | |
| 881 | 1,690 | 1,800 | 2,603 | 1,273 | 919 | 186 | 342 | 386 | 250 | 339 | 118 | 154 | |
| Total Liabilities | 3,804 | 5,095 | 5,581 | 5,759 | 4,607 | 4,051 | 2,243 | 2,212 | 2,151 | 2,085 | 2,486 | 2,394 | 2,450 |
| 13 | 9 | 5 | 2 | 1 | 0 | 2 | 1 | 2 | 4 | 15 | 16 | 21 | |
| CWIP | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Investments | 3,714 | 4,897 | 5,079 | 5,319 | 4,338 | 3,940 | 2,121 | 2,112 | 2,066 | 1,960 | 2,284 | 2,265 | 2,254 |
| 77 | 189 | 497 | 438 | 268 | 111 | 119 | 98 | 82 | 122 | 187 | 113 | 174 | |
| Total Assets | 3,804 | 5,095 | 5,581 | 5,759 | 4,607 | 4,051 | 2,243 | 2,212 | 2,151 | 2,085 | 2,486 | 2,394 | 2,450 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -24 | 8 | -67 | 479 | -93 | 93 | -262 | -26 | -10 | -1 | -19 | -35 | |
| -595 | -1,143 | -116 | -0 | 0 | -51 | 493 | -86 | -53 | -63 | -311 | 43 | |
| 572 | 1,155 | 229 | -552 | 94 | -41 | -233 | 115 | 60 | 74 | 320 | 25 | |
| Net Cash Flow | -47 | 20 | 47 | -73 | 1 | 1 | -1 | 3 | -3 | 10 | -10 | 33 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Working Capital Days | 178 | 282 | -724 | -2,094 | 52 | -4,047 | -576 | -866 | -4,043 | -363 | -2,632 | 285 |
| ROCE % | -6% | 3% | 5% | 3% | 4% | 0% | -11% | -5% | -7% | 4% | -1% | 0% |
Documents
Announcements
- Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 30 Apr
- Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 30 Apr
- Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 30 Apr
- Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 (SEBI Listing Regulations) 29 Apr
-
Certificate As per Regulation 40(10)
23 Apr - Certificate As per Regulation 40(10) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 from a Company Secretary in practice for the year ended …
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
Services
A)Lending (15% of the revenue in FY21) Lending and Investments, Financial Advisory Services, Distribution of Third-Party Financial Products. The Co. provides SME Finance through Religare Finvest Ltd.(RFL) and Affordable Housing Finance through Religare Housing Development Finance Corporation Ltd.(RHDFCL)
B)Health Insurance (74.5% of the revenue) Offers products in the retail segment for Health Insurance, Critical Illness, Personal Accident, Top-up Coverage, International Travel Insurance and Maternity along with Group Health Insurance and Group Personal Accident Insurance for corporates through Care Health Insurance Limited (formerly known as Religare Health Insurance Co. Ltd.)[1]
C)Retail Broking (8.5% of the revenue)Broking in Securities and Commodities, Custodial and Depository Operations, PMS, Institutional Equities and Investment Banking Services through Religare Broking Ltd.[2] [3]